Humacyte Inc (HUMA)
6.33
-0.09
(-1.40%)
USD |
NASDAQ |
May 17, 16:00
6.35
+0.02
(+0.32%)
After-Hours: 20:00
Humacyte Enterprise Value: 638.30M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 638.30M |
| May 16, 2024 | 649.02M |
| May 15, 2024 | 654.97M |
| May 14, 2024 | 649.02M |
| May 13, 2024 | 537.08M |
| May 10, 2024 | 444.19M |
| May 09, 2024 | 422.76M |
| May 08, 2024 | 421.57M |
| May 07, 2024 | 433.47M |
| May 06, 2024 | 425.14M |
| May 03, 2024 | 409.66M |
| May 02, 2024 | 408.47M |
| May 01, 2024 | 408.47M |
| April 30, 2024 | 351.31M |
| April 29, 2024 | 371.55M |
| April 26, 2024 | 359.64M |
| April 25, 2024 | 348.92M |
| April 24, 2024 | 339.40M |
| April 23, 2024 | 352.50M |
| April 22, 2024 | 325.11M |
| April 19, 2024 | 325.11M |
| April 18, 2024 | 312.01M |
| April 17, 2024 | 256.04M |
| April 16, 2024 | 248.89M |
| April 15, 2024 | 226.27M |
| Date | Value |
|---|---|
| April 12, 2024 | 227.46M |
| April 11, 2024 | 244.13M |
| April 10, 2024 | 240.56M |
| April 09, 2024 | 246.51M |
| April 08, 2024 | 253.66M |
| April 05, 2024 | 246.51M |
| April 04, 2024 | 256.04M |
| April 03, 2024 | 245.32M |
| April 02, 2024 | 238.18M |
| April 01, 2024 | 242.94M |
| March 28, 2024 | 289.90M |
| March 27, 2024 | 288.71M |
| March 26, 2024 | 285.14M |
| March 25, 2024 | 293.47M |
| March 22, 2024 | 313.72M |
| March 21, 2024 | 348.25M |
| March 20, 2024 | 330.14M |
| March 19, 2024 | 327.80M |
| March 18, 2024 | 330.14M |
| March 15, 2024 | 298.55M |
| March 14, 2024 | 289.19M |
| March 13, 2024 | 304.40M |
| March 12, 2024 | 306.74M |
| March 11, 2024 | 283.35M |
| March 08, 2024 | 313.76M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
65.14M
Minimum
Dec 28 2022
1.713B
Maximum
Sep 01 2021
351.96M
Average
248.89M
Median
Apr 16 2024
Enterprise Value Benchmarks
| Aquestive Therapeutics Inc | 216.71M |
| Adial Pharmaceuticals Inc | 3.458M |
| Gritstone Bio Inc | 79.51M |
| Precision BioSciences Inc | -29.43M |
| Puma Biotechnology Inc | 190.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.90M |
| Total Expenses (Quarterly) | 26.58M |
| EPS Diluted (Quarterly) | -0.29 |
| Earnings Yield | -15.80% |